title: Poor prognosis in children with acute nonlymphoblastic leukemia in Turkey.
abstract: Two hundred fourteen children with acute nonlymphoblastic leukemia (ANLL) were diagnosed between July 1975 to January 1987 in our center. Only 106 (50%) of the children could be treated. An initial hematologic remission was attained in 61 (58%) with a median duration of hematologic remission of 7.5 months and median survival of 12 months. Five patients who completed 36 months of therapy are still in initial remission, less than or equal to 84 months. Exophthalmos at presentation, which is clearly related to shorter duration of remission, was observed in 11% of these children. In two cases, it was the first sign of leukemia, 6 and 7 months prior to obvious bone marrow involvement. Twenty percent of the 61 patients who achieved remission discontinued their chemotherapy during the course of treatment while they were in remission, which indicates a different problem in the treatment of these patients in Turkey. Despite administration of similar treatment protocols, the prognosis of our patients was worse than the results observed in developed countries. We conclude that poor socioeconomic and nutritional conditions should also be considered among the high-risk factors for children with ANLL, as experienced in our patients with acute lymphoblastic leukemia (ALL).
authors.affiliation: Department of Pediatric Hematology, Hacettepe University, Ankara, Turkey.
authors.forename: G
authors.initials: G
authors.lastname: Hiçsönmez
authors.forename: A
authors.initials: A
authors.lastname: Gürgey
authors.forename: V P
authors.initials: VP
authors.lastname: Zamani
authors.forename: S
authors.initials: S
authors.lastname: Yetgin
authors.forename: C
authors.initials: C
authors.lastname: Altay
authors.forename: S
authors.initials: S
authors.lastname: Ozsoylu
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D014421:Turkey